Polymorphism of NAD(P)H:quinone oxidoreductase (NQO1) pro187ser and prognosis of non-small cell lung cancer after radiation therapy

被引：0
|
作者：
Choi, E
Park, H
Song, S
Yoon, S
Lee, S
Shin, S
Kim, J
Hong, Y
Lee, J
机构：
[1] Univ Ulsan, Dept Radiat Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea
[2] Univ Ulsan, Dept Internal Med, Asan Med Ctr, Coll Med, Seoul, South Korea
[3] Inha Univ, Dept Microbiol, Coll Med, Inchon, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)81203-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S305 / S305
页数：1
相关论文
共 50 条
  • [41] Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis
    Yuan, Weiguang
    Xu, Lidan
    Chen, Wangyang
    Wang, Lihong
    Fu, Zhenkun
    Pang, Da
    Li, Dianjun
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (02) : 467 - 472
  • [42] Comment on ‘The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis’
    M A Malik
    British Journal of Cancer, 2014, 111 : 2200 - 2200
  • [43] Comment on 'The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis'
    Malik, M. A.
    BRITISH JOURNAL OF CANCER, 2014, 111 (11) : 2200 - 2200
  • [44] Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis
    Yu, Jie
    Zhong, Bingling
    Zhao, Lin
    Hou, Ying
    Ai, Nana
    Lu, Jin-Jian
    Ge, Wei
    Chen, Xiuping
    DRUG RESISTANCE UPDATES, 2023, 70
  • [45] Reply: Comment on 'The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis'
    Lajin, B.
    Alachkar, A.
    BRITISH JOURNAL OF CANCER, 2014, 111 (11) : 2201 - 2201
  • [46] NAD(P)H:quinone oxidoreductase (NQO1) loss of function in Burkitt's lymphoma cell lines
    Bruge, Francesca
    Virgili, Samantha
    Cacciamani, Tiziana
    Principi, Federica
    Tiano, Luca
    Littarru, Gian Paolo
    BIOFACTORS, 2008, 32 (1-4) : 71 - 81
  • [47] NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer
    Cui, Xuelian
    Jin, Tiefeng
    Wang, Xiaoyan
    Jin, Guang
    Li, Zhuhu
    Lin, Lijuan
    ONCOLOGY REPORTS, 2014, 32 (06) : 2589 - 2595
  • [48] Reply to ‘Comment on: The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis’
    B Lajin
    A Alachkar
    British Journal of Cancer, 2014, 111 : 2202 - 2202
  • [49] Immunodetection of GLUT-1 AND NQO1 (NAD(P)H:quinone oxidoreductase) in superficial bladder cancer.
    Palit, V
    Basu, S
    Bibby, MC
    Shah, T
    Gill, JH
    Phillips, RM
    BRITISH JOURNAL OF CANCER, 2003, 88 : S30 - S30
  • [50] Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer
    Wu, Xingsen
    Li, Xiang
    Li, Zhihong
    Yu, Yancheng
    You, Qidong
    Zhang, Xiaojin
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (24) : 11280 - 11297
12345